As we close out the first half of 2014, its time to take a look back at the year-to-date U.S. stock market gainers and losers.
- U.S. Stock Market's Five Best and Worst Performers in 2014's First Half
- These 10 Nasdaq Stocks Are the Index's Best Year-to-Date Performers
- Actavis to Buy Forest Labs (NYSE: FRX) in $25 Billion Blockbuster Deal
Anyone who did not "sell in May and go away" has likely enjoyed stock gains - especially in Nasdaq stocks.
But, it's the Nasdaq Composite sporting the most intense rebound after two months in the red. The Nasdaq fell 4.2% from January to mid-April, but is up nearly 6% since then.
Last week's $45.2 billion Time Warner-Comcast deal pushed the global deal tally to $336 billion so far this year - the most since 2007 - and another blockbuster deal announced this week will push that figure even higher.
On Tuesday Irish drugmaker Actavis PLC (NYSE: ACT), producer of generic and specialty urology and women's health products, agreed to buy New York-based Forest Laboratories Inc. (NYSE: FRX) for $25 billion.